MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to the field of human health, and more particularly to the treatment of attention deficit/hyperactivity disorder (ADHD) with mazindol. The latter can be administered as monotherapy or in combination with one or more compounds, including psychostimulants, for the indication of ADHD and associated or co-morbid symptoms.
2 Citations
17 Claims
-
10-15. -15. (canceled)
- 16. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and mazindol.
Specification